Abstract
To determine the distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas, formalin-fixed paraffin-embedded tissue from 527 cases of these tumors was studied using a monoclonal antibody to CA 19-9 and an avidin-biotin immunohistochemical technique. Positive reactivity was seen in some tumors of all types except hepatocellular carcinoma. Positive reactions were most common in pancreatic adenocarcinomas (94%), bile duct carcinomas (91%), and transitional cell carcinomas (76%). The majority of tumors from the ovary, endometrium, distal esophagus/stomach, and colon also showed positive staining. Immunoreactivity was seen in 25-29% of carcinomas of the lung, thyroid, and endocervix. Few positive reactions were seen in renal cell carcinomas (2%), prostatic adenocarcinomas (3%), and breast carcinomas (6%). It was concluded that CA 19-9 is frequently present in several types of adenocarcinoma and transitional cell carcinoma. Immunostaining for CA 19-9 may be helpful in excluding hepatocellular carcinoma, prostatic adenocarcinoma, and renal cell carcinoma in certain clinical settings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
